Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00460187 · ClinicalTrials.gov registry record · NA
EPIC US Pivotal Study
A NA study of Percutaneous Intervention of the Carotid Arteries., sponsored by Lumen Biomedical.
- Completed
- Registry status
- NA
- Development phase
- 237
- Enrollment target
- 2
- Study locations
NCT00460187: Completed NA study of Percutaneous Intervention of the Carotid Arteries., sponsored by Lumen Biomedical.
NCT00460187 is a NA study of Percutaneous Intervention of the Carotid Arteries. that has completed, run by Lumen Biomedical. The registered enrollment target is 237 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00460187, a NA study of Percutaneous Intervention of the Carotid Arteries., has completed, sponsored by Lumen Biomedical.
- COMPLETED
- Registry status
- NA
- Development phase
- 237 participants
- Enrollment target
- 2
- Study locations
Study Summary
Multicenter, prospective, pivotal study designed to demonstrate the safety and efficacy of the Lumen Biomedical, Inc. FiberNet® Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention in high surgical risk patients.
Conditions Studied
Interventions
- DEVICE Percutaneous intervention of the carotid artery
Study Locations (2)
California
- Hoag Hospital - Newport Beach
South Dakota
- Heart Hospital of South Dakota - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-06 |
| Phase | NA |
What the finished NCT00460187 record still lists
NCT00460187 is an interventional study that assigns participants to a tested intervention. The registered 237 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Percutaneous Intervention of the Carotid Arteries. appearing as the primary indexed condition, and to 1 intervention - of which Percutaneous intervention of the carotid artery is the first listed.
NCT00460187 reports a single indexed study location in California, South Dakota.
Frequently Asked Questions
What is clinical trial NCT00460187 about?
NCT00460187 is a clinical study titled "EPIC US Pivotal Study". Multicenter, prospective, pivotal study designed to demonstrate the safety and efficacy of the Lumen Biomedical, Inc. FiberNet® Embolic Protection System as an adjunctive device during carotid artery percutaneous intervention in high surgical risk patients.
What is the current status of trial NCT00460187?
This trial is currently completed. It is a NA study. The enrollment target is 237 participants. The study started on 2007-03. Estimated completion is 2008-06.
What conditions does trial NCT00460187 study?
This clinical trial studies the following conditions: Percutaneous Intervention of the Carotid Arteries..
What interventions are being tested in trial NCT00460187?
The interventions under investigation include: Percutaneous intervention of the carotid artery (DEVICE).
Who is sponsoring clinical trial NCT00460187?
This trial is sponsored by Lumen Biomedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00460187 being conducted?
This trial has 2 study locations across California, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00460187's enrollment target sits among peer trials
237 461st of 2000 higher than 1,540 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05974176 · 237 participants · NA
Considering Racial and Acculturation Stress in Addressing Trauma
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia